Literature DB >> 2786497

SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.

A Juretic1, B B Knowles.   

Abstract

The ability of normal mice to mount an SV40 T antigen-specific cytolytic T lymphocytes response when immunized in vivo with splenocytes from the SV40 T antigen transgenic 427-line mice and restimulated in vitro with SV40-transformed fibroblasts, or when immunized with SV40 and restimulated with 427-line splenocytes, was analyzed. Both immunization schemes resulted in an SV40 T antigen-specific immune response, indicating the presence of SV40 T antigen-positive cells in the spleens of these transgenic mice. Normal mice engrafted with skin from 427 donors showed no rejection of the graft. Thus, SV40 T antigen in transgenic 427-line mice is expressed on an undefined cell type in the spleen and acts as a tissue-specific minor histocompatibility antigen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786497     DOI: 10.1007/bf00375864

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  11 in total

1.  A rapid method of grafting skin on tails of mice.

Authors:  D W BAILEY; B USAMA
Journal:  Transplant Bull       Date:  1960-04

2.  Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

3.  The effect of thymus environment on T cell development and tolerance.

Authors:  P Marrack; D Lo; R Brinster; R Palmiter; L Burkly; R H Flavell; J Kappler
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

4.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen.

Authors:  B B Knowles; M Koncar; K Pfizenmaier; D Solter; D P Aden; G Trinchieri
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

5.  Generation of cytotoxic T lymphocytes by the H-2-encoded E molecules.

Authors:  A Juretić; Z A Nagy; J Klein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.

Authors:  R L Brinster; H Y Chen; A Messing; T van Dyke; A J Levine; R D Palmiter
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

7.  Serologically demonstrable alloantigens of mouse epidermal cells.

Authors:  M Scheid; E A Boyse; E A Carswell; L J Old
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

8.  SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.

Authors:  P J Wettstein; L Jewett; S Faas; R L Brinster; B B Knowles
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.

Authors:  R D Palmiter; H Y Chen; A Messing; R L Brinster
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

10.  Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.

Authors:  S J Faas; S Pan; C A Pinkert; R L Brinster; B B Knowles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  2 in total

1.  Do we need a pepton hypothesis?

Authors:  K F Lindahl
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.

Authors:  A Juretic; G C Spagnoli; H Hörig; R Shipman; T Kocher; M Samija; M Turic; D Eljuga; F Harder; M Heberer
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.